Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056067 · ClinicalTrials.gov registry record · NA
Hormones and Physical Exercise (HOPE) Study
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT02056067 is a NA study that has completed, run by Yale University. The registered enrollment target is 121 participants.
The verdict
NCT02056067, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
The investigators propose to examine 121 postmenopausal women diagnosed with hormone-receptor positive breast cancer who have been taking aromatase inhibitors (AI) for at least 6 months and are experiencing at least mild arthralgia originating during AI treatment, the yearlong effect of exercise vs. attention control (health education), and on toxic side effects of AI.
Interventions
- BEHAVIORAL Exercise
- BEHAVIORAL Attention Control (Health Education)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02056067
The ClinicalTrials.gov registry entry for NCT02056067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.
NCT02056067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02056067 about?
NCT02056067 is a clinical study titled "Hormones and Physical Exercise (HOPE) Study". The investigators propose to examine 121 postmenopausal women diagnosed with hormone-receptor positive breast cancer who have been taking aromatase inhibitors (AI) for at least 6 months and are experiencing at least mild arthralgia originating during AI treatment, the yearlong effect of exercise vs....
What is the current status of trial NCT02056067?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2009-06. Estimated completion is 2013-06.
What interventions are being tested in trial NCT02056067?
The interventions under investigation include: Exercise (BEHAVIORAL), Attention Control (Health Education) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02056067?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.